Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome
- PMID: 3142595
- PMCID: PMC1834779
- DOI: 10.1136/bmj.297.6655.1024
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome
Abstract
Women with the polycystic ovary syndrome do not respond well to treatment with luteinising hormone releasing hormone. To determine whether this might be due to an underlying endocrine disturbance basal concentrations of luteinising hormone were measured in 54 infertile women treated with pulsatile luteinising hormone releasing hormone and concentrations at the time of maximum follicular growth were measured in 23 of the patients. Forty one patients ovulated. Forty one patients ovulated and 27 conceived, but nine pregnancies terminated within four weeks after ovulation. Basal luteinising hormone concentrations were significantly lower in those who conceived (12.4 (range 1.3-29.0) IU/l) than in those who did not (19.0 (3.5-50.0) IU/l) and in those whose pregnancy progressed (9.6 (1.3-29.0) IU/l) than in those with early loss of pregnancy (17.9 (7.0-29.0) IU/l). Concentrations at the time of maximum follicular growth were significantly lower in women who ovulated (9.4 (2.9-35.4) IU/l) than in those who did not (29.0 (7.0-50.0) IU/l) and in those who conceived (6.2 (2.9-8.5) IU/l) than in those who did not (17.9 (4.0-50.0) IU/l). These results indicate that high concentrations of luteinising hormone during the follicular phase in women with polycystic ovaries have a deleterious effect on rates of conception and may be a causal factor in early pregnancy loss.
Similar articles
-
One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation.BMJ. 1989 Mar 25;298(6676):809-12. doi: 10.1136/bmj.298.6676.809. BMJ. 1989. PMID: 2496866 Free PMC article.
-
Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.J Clin Endocrinol Metab. 1991 May;72(5):965-72. doi: 10.1210/jcem-72-5-965. J Clin Endocrinol Metab. 1991. PMID: 1902487
-
Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.Am J Obstet Gynecol. 1990 Nov;163(5 Pt 2):1737-42. doi: 10.1016/0002-9378(90)91438-i. Am J Obstet Gynecol. 1990. PMID: 2122730
-
Adverse effects of luteinizing hormone on fertility: fact or fantasy.Baillieres Clin Obstet Gynaecol. 1998 Dec;12(4):555-63. doi: 10.1016/s0950-3552(98)80051-5. Baillieres Clin Obstet Gynaecol. 1998. PMID: 10627767 Review.
-
Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.Cochrane Database Syst Rev. 2000;(2):CD000412. doi: 10.1002/14651858.CD000412. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2004;(1):CD000412. doi: 10.1002/14651858.CD000412.pub2 PMID: 10796718 Updated. Review.
Cited by
-
Endocrine dysfunction and recurrent spontaneous abortion: An overview.Int J Appl Basic Med Res. 2016 Apr-Jun;6(2):79-83. doi: 10.4103/2229-516X.179024. Int J Appl Basic Med Res. 2016. PMID: 27127734 Free PMC article.
-
Recurrent early miscarriage and polycystic ovaries.BMJ. 1988 Oct 22;297(6655):1027-8. doi: 10.1136/bmj.297.6655.1027. BMJ. 1988. PMID: 3142597 Free PMC article. No abstract available.
-
[Pulsatile therapy with LHRH].Arch Gynecol Obstet. 1989;246 Suppl:S38-44. doi: 10.1007/BF00935851. Arch Gynecol Obstet. 1989. PMID: 2686560 Review. German. No abstract available.
-
Statins in the treatment of polycystic ovary syndrome.Semin Reprod Med. 2008 Jan;26(1):127-38. doi: 10.1055/s-2007-992933. Semin Reprod Med. 2008. PMID: 18181091 Free PMC article. Review.
-
Hypersecretion of basal luteinizing hormone and an increased risk of pregnancy loss among women with polycystic ovary syndrome undergoing controlled ovarian stimulation and intrauterine insemination.Heliyon. 2023 May 13;9(5):e16233. doi: 10.1016/j.heliyon.2023.e16233. eCollection 2023 May. Heliyon. 2023. PMID: 37234655 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical